Source comparison
Time Tesamorelin + Ipamorelin Blend Doses: Synergistic Pulsatile GH Release Comparison
Standard 1:1 Evening Blend 250–500mcg 30 min pre-bed 4–5× baseline nocturnal pulse Visceral fat reduction, metabolic studies Most validated protocol for lipolytic outcomes. Amplifies natural nocturnal GH surge 2:1 GHRH-Heavy Protocol 500mcg 250mcg 3.5–4× basel
This comparison does not assign a generated winner or score.
- Standard 1:1 Evening Blend
- 250–500mcg
- 30 min pre-bed
- 4–5× baseline nocturnal pulse
- Visceral fat reduction, metabolic studies
- Most validated protocol for lipolytic outcomes. Amplifies natural nocturnal GH surge
- 2:1 GHRH-Heavy Protocol
- 500mcg
- 250mcg
- 3.5–4× baseline pulse
- Advanced protocols after receptor adaptation
- Used when prior GH secretagogue exposure requires increased GHRH signaling
- Pre-Workout Acute Blend
- 250–350mcg
- 30–45 min pre-training
- 3–4× baseline pulse
- Acute lipolysis during exercise
- Secondary timing option. Synergizes with training-induced catecholamine surge
- Monotherapy (Tesamorelin Only)
- 0
- 1.5–2× baseline pulse
- Comparative baseline for synergy studies
- Effective but significantly weaker than blend. Requires higher dose for equivalent outcomes
- Monotherapy (Ipamorelin Only)
- 1.8–2.2× baseline pulse
- GHRP receptor studies
- More potent than tesamorelin alone but still suboptimal vs blend